| Home > Publications Database > Axon Regeneration in the Central Nervous System: Facing the Challenges from the Inside. > print |
| 001 | 140301 | ||
| 005 | 20240321220801.0 | ||
| 024 | 7 | _ | |a 10.1146/annurev-cellbio-100617-062508 |2 doi |
| 024 | 7 | _ | |a pmid:30044649 |2 pmid |
| 024 | 7 | _ | |a 0743-4634 |2 ISSN |
| 024 | 7 | _ | |a 1081-0706 |2 ISSN |
| 024 | 7 | _ | |a 1530-8995 |2 ISSN |
| 024 | 7 | _ | |a 2331-1045 |2 ISSN |
| 024 | 7 | _ | |a altmetric:45556673 |2 altmetric |
| 037 | _ | _ | |a DZNE-2020-06623 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 570 |
| 100 | 1 | _ | |a Curcio, Michele |0 P:(DE-2719)2811540 |b 0 |e First author |u dzne |
| 245 | _ | _ | |a Axon Regeneration in the Central Nervous System: Facing the Challenges from the Inside. |
| 260 | _ | _ | |a Palo Alto, Calif. |c 2018 |b Annual Reviews |
| 264 | _ | 1 | |3 print |2 Crossref |b Annual Reviews |c 2018-10-06 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1685109956_10312 |2 PUB:(DE-HGF) |x Review Article |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a After an injury in the adult mammalian central nervous system (CNS), lesioned axons fail to regenerate. This failure to regenerate contrasts with axons' remarkable potential to grow during embryonic development and after an injury in the peripheral nervous system (PNS). Several intracellular mechanisms-including cytoskeletal dynamics, axonal transport and trafficking, signaling and transcription of regenerative programs, and epigenetic modifications-control axon regeneration. In this review, we describe how manipulation of intrinsic mechanisms elicits a regenerative response in different organisms and how strategies are implemented to form the basis of a future regenerative treatment after CNS injury. |
| 536 | _ | _ | |a 341 - Molecular Signaling (POF3-341) |0 G:(DE-HGF)POF3-341 |c POF3-341 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 2 | |a Animals |2 MeSH |
| 650 | _ | 2 | |a Axonal Transport: genetics |2 MeSH |
| 650 | _ | 2 | |a Axons: metabolism |2 MeSH |
| 650 | _ | 2 | |a Axons: physiology |2 MeSH |
| 650 | _ | 2 | |a Central Nervous System: growth & development |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Mammals |2 MeSH |
| 650 | _ | 2 | |a Nerve Regeneration: genetics |2 MeSH |
| 650 | _ | 2 | |a Peripheral Nervous System: growth & development |2 MeSH |
| 700 | 1 | _ | |a Bradke, Frank |0 P:(DE-2719)2810270 |b 1 |e Last author |u dzne |
| 773 | 1 | 8 | |a 10.1146/annurev-cellbio-100617-062508 |b : Annual Reviews, 2018-10-06 |n 1 |p 495-521 |3 journal-article |2 Crossref |t Annual Review of Cell and Developmental Biology |v 34 |y 2018 |x 1081-0706 |
| 773 | _ | _ | |a 10.1146/annurev-cellbio-100617-062508 |g Vol. 34, no. 1, p. 495 - 521 |0 PERI:(DE-600)1470447-X |n 1 |q 34:1<495 - 521 |p 495-521 |t Annual review of cell and developmental biology |v 34 |y 2018 |x 1081-0706 |
| 856 | 4 | _ | |u https://www.annualreviews.org/doi/10.1146/annurev-cellbio-100617-062508 |
| 909 | C | O | |p VDB |o oai:pub.dzne.de:140301 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 0 |6 P:(DE-2719)2811540 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 1 |6 P:(DE-2719)2810270 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-341 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Molecular Signaling |x 0 |
| 914 | 1 | _ | |y 2018 |
| 915 | _ | _ | |a Allianz-Lizenz / DFG |0 StatID:(DE-HGF)0400 |2 StatID |d 2022-11-18 |w ger |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b ANNU REV CELL DEV BI : 2021 |d 2022-11-18 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-18 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-18 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2022-11-18 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2022-11-18 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-18 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-18 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-18 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1120 |2 StatID |b BIOSIS Reviews Reports And Meetings |d 2022-11-18 |
| 915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b ANNU REV CELL DEV BI : 2021 |d 2022-11-18 |
| 920 | _ | _ | |l yes |
| 920 | 1 | _ | |0 I:(DE-2719)1013002 |k AG Bradke |l Axon Growth and Regeneration |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)1013002 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|